Strategic Intelligence: Precision Medicine (2025)
Description
Strategic Intelligence: Precision Medicine (2025)
Summary
Precision medicine is revolutionizing healthcare by tailoring medical treatment plans to individual patients based on their genetic makeup, lifestyle, and environmental factors. The integration of big data, bioinformatics, and AI technologies is enabling healthcare providers to predict disease risks, personalize treatment plans, and improve patient outcomes. This approach moves beyond the traditional one size fits all medical approach, incorporating advanced data analytics and genomic insights to provide more effective and personalized care.
Scope
Summary
Precision medicine is revolutionizing healthcare by tailoring medical treatment plans to individual patients based on their genetic makeup, lifestyle, and environmental factors. The integration of big data, bioinformatics, and AI technologies is enabling healthcare providers to predict disease risks, personalize treatment plans, and improve patient outcomes. This approach moves beyond the traditional one size fits all medical approach, incorporating advanced data analytics and genomic insights to provide more effective and personalized care.
Scope
- Precision medicine is advancing diagnostics.
- Recent advancements in precision medicine are particularly evident in oncology.
- The precision medicine landscape is shaped by macroeconomic and regulatory trends.
- Understand the major players in the precision medicine space, as well as the future of the theme.
- Learn about the different technology, macro, and regulatory trends impacting precision medicine.
- Learn about industry growth and the key advancements in precision medicine.
Table of Contents
- Executive Summary
- Players
- Technology Briefing
- Data analytics
- Bioinformatics
- Gene sequencing
- Artificial intelligence
- 3D printing
- Trends
- Technology trends
- Macroeconomic trends
- Regulatory trends
- Industry Analysis
- Industry growth
- Case study: liquid biopsy for cancer
- Modernizing oncology screening and monitoring
- Challenges of earlier detection of cancer
- Regulatory adoption of liquid biopsy for cancer
- Other use cases
- Wearables and digital biomarkers for chronic disease management
- Point-of-care and decentralized molecular diagnostic devices
- Pharmacogenomic and genetic devices in psychiatry and cardiology
- 3D-bioprinted scaffolds and implants in regenerative medicine
- Software enabling precision medicine insights and workflows
- Timeline
- Value Chain
- Technology
- Data analytics
- Bioinformatics
- Gene sequencing
- Artificial intelligence
- 3D printing
- Diagnostics and devices
- Molecular diagnostics
- Drug delivery devices
- Stationary devices
- Services
- Tools and platforms
- Companies
- Public companies
- Private companies
- Sector Scorecards
- Medical devices sector scorecard
- Who’s who
- Thematic screen
- Valuation screen
- Risk screen
- Glossary
- Further Reading
- GlobalData reports
- Our Thematic Research Methodology
- About GlobalData
- Contact Us
- List of Tables
- Table 1: Technology trends
- Table 2: Macroeconomic trends
- Table 3: Regulatory trends
- Table 4: Public companies
- Table 5: Private companies
- Table 6: Glossary
- Table 7: GlobalData reports
- List of Figures
- Figure 1: Who are the leading players in the precision medicine theme, and where do they sit in the value
- Figure 2: Widespread support for precision medicine adoption in healthcare
- Figure 3: Cancer cases are climbing in the US
- Figure 4: Liquid biopsy device pipeline
- Figure 5: The precision medicine story
- Figure 6: The precision medicine value chain - Technologies, devices, and services within the theme
- Figure 7: The precision medicine value chain - Big data market leaders vs. challengers
- Figure 8: The precision medicine value chain - Bioinformatics market leaders vs. challengers
- Figure 9: The precision medicine value chain - Gene sequencing market leaders vs. challengers
- Figure 10: The precision medicine value chain - Artificial intelligence market leaders vs. challengers
- Figure 11: The precision medicine value chain - 3D-printing market leaders vs. challengers
- Figure 12: The precision medicine value chain - Molecular diagnostics market leaders vs. challengers
- Figure 13: The precision medicine value chain - Drug delivery devices market leaders vs. challengers
- Figure 14: The precision medicine value chain - Stationary devices market leaders vs. challengers
- Figure 15: The precision medicine value chain - Tools and platforms market leaders vs. challengers
- Figure 16: Who does what in the medical devices space?
- Figure 17: Thematic screen
- Figure 18: Valuation screen
- Figure 19: Risk screen
- Figure 20: Our five-step approach for generating a sector scorecard
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


